Skip to main content
IALVS logo gray

6877 N High Street Suite 100, Worthington, OH 43085

6877 N High Street Suite 100, Worthington, OH 43085

Spring-Mauve-flowers
Home » What's New » New Survey: Less than Half of United States Adults with Diabetes Understand Their Risk for Vision Loss

New Survey: Less than Half of United States Adults with Diabetes Understand Their Risk for Vision Loss

A new survey released this month by Regeneron Pharmaceuticals, Inc. reveals that less than half of recently surveyed United States adults with diabetes recognize their risk for vision loss. Regeneron is a science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

[Please note: Regeneron Pharmaceuticals, Inc., which commissioned this survey, is also the developer of the injectable drug EYLEA, approved by the FDA in 2014 for the treatment of diabetic macular edema.]

Adjust Text Size Normal Large Extra Large